Your dog gets up slowly in the morning. She used to bound off her bed now she stands and stretches for a few seconds before walking. She still runs for a ball, but stops sooner than she used to. On cold mornings, she's stiffer. She doesn't complain. She never cries.
That quiet stoicism is exactly what makes arthritis in dogs so easy to miss.
By the time most Indian dog owners suspect arthritis, it has been there for months sometimes years. This is one of the most common conditions in dogs, it causes real pain, and it is also one of the most manageable when caught and addressed properly.
Here is everything you need to know.
Key Takeaways
- Osteoarthritis (OA), also called degenerative joint disease (DJD), is the most common chronic, painful condition recognised in dogs and one of the most underdiagnosed.
- According to the Merck Veterinary Manual, up to 40% of dogs aged 8 months to 4 years already have OA on X-ray though clinical signs generally don't appear until 5–13 years.
- An estimated 80–90% of dogs and cats will suffer from arthritis in middle age, making it essentially a universal condition in dogs as they age.
- OA begins with cartilage deterioration that can be caused by trauma, infection, immune-mediated disease, or most commonly in dogs developmental joint abnormalities like hip dysplasia and elbow dysplasia.
- Dogs rarely cry from chronic pain. Behavioural changes slower to rise, reluctance to climb stairs, shorter walks, personality shifts are the real early warning signs.
- Treatment is multimodal: weight optimisation is the most impactful single intervention; omega-3 fatty acid supplementation has documented gait and mobility benefits; NSAIDs are the most predictably effective pharmaceutical treatment.
- Arthritis is a lifetime condition that requires ongoing management, not a one-time fix.
What Is Arthritis in Dogs?
Osteoarthritis (OA) — also called degenerative joint disease (DJD) — is progressive deterioration of cartilage in freely moving joints. As the cartilage breaks down, the joint loses its smooth, well-cushioned function and becomes inflamed, painful, and increasingly dysfunctional.
According to the Merck Veterinary Manual, it is characterised by:
- Thinning of cartilage — the smooth, rubbery shock absorber between bones is worn down
- Buildup of fluid within the joint — inflamed tissue produces excess synovial fluid, causing swelling
- Formation of bony outgrowths (osteophytes) — the body attempts to stabilise the damaged joint by laying down extra bone around its margins, but these spurs cause further pain and limit movement
The Merck Veterinary Manual Professional Version describes the disease as not just affecting the cartilage but as a condition of the entire joint organ and indeed of the entire musculoskeletal system. As a dog compensates for a painful hip by loading the opposite leg, or for a painful elbow by shifting to the hindquarters, secondary strain on those compensating structures begins a second wave of problems.
In approximately one-quarter of affected dogs, OA also involves a neuropathic pain component where the nervous system itself becomes sensitised to pain, amplifying the signal even when the structural damage is modest. This is why some dogs appear to be in more pain than their X-rays would suggest.
A simple way to understand it: the joint works like a door hinge with cartilage as the lubricant. When the lubricant degrades, the metal grinds on metal. Every movement creates friction and inflammation. And once that cycle starts, it feeds on itself.
What Causes Arthritis? The Disease Cascade
The Merck Veterinary Manual identifies the primary causes of joint degeneration as trauma, infection, immune-mediated disease, and malformation during development.
In dogs, developmental malformations are by far the most common underlying cause particularly hip dysplasia, elbow dysplasia, luxating patella, osteochondritis dissecans (OCD), and cranial cruciate ligament (CCL) disease.
Here is the disease cascade:
- The inciting cause a poorly fitting hip socket, an elbow that didn't develop correctly, a ligament that has partially torn creates abnormal loading on the joint surfaces.
- This triggers chondrocyte (cartilage cell) necrosis cartilage cells begin dying.
- Dying cartilage cells release degradative enzymes that attack the cartilage matrix, and proinflammatory mediators that inflame the joint lining (synovitis).
- The inflamed synovium becomes richly supplied with new blood vessels and nerve endings this innervated synovitis is a primary driver of OA pain.
- As cartilage thins, the subchondral bone (the layer beneath the cartilage) is eventually exposed. This bone is innervated once exposed, every movement is painful.
- The joint capsule thickens and scars (fibrosis), ligaments and tendons are stressed beyond their design capacity, and surrounding muscles atrophy from disuse.
- The dog redistributes weight away from the painful joint, creating strain on alternative limbs, which then develop secondary OA over time.
The key insight: OA is a condition of the entire musculoskeletal system, not just one joint. A dog with hip OA will often develop secondary stifle (knee) OA, then shoulder OA from forequarter loading. Treatment that addresses the entire system weight, exercise, muscle maintenance, pain management is more effective than treating a single joint in isolation.
How Common Is Arthritis in Indian Dogs?
More common than almost any dog owner expects.
The Merck Veterinary Manual Professional Version cites research showing that up to 40% of dogs aged 8 months to 4 years already have radiographic evidence of OA meaning the X-ray changes are there, even though the dog shows no obvious lameness. Clinical signs typically do not appear until dogs are 5–13 years old.
Across all species, OA is estimated to affect 80–90% of dogs and cats in middle age.
For Indian dog owners, this matters particularly because:
Breeds popular in India are among the highest-risk breeds. German Shepherds, Labradors, Golden Retrievers, Rottweilers, and Great Danes all carry high predisposition to hip and elbow dysplasia the most common precursors to OA. The Merck Veterinary Manual Professional Version's table of heritable conformational conditions lists Labrador Retrievers as high-risk for fragmented medial coronoid process, OCD in shoulder, elbow and hock, and CCL injury. German Shepherd Dogs have the highest risk of degenerative joint disease from CCL disease compared to Labrador Retrievers, Golden Retrievers, and Rottweilers combined.
Excess body weight accelerates the disease. India's culture of feeding dogs table scraps roti, rice, dal, leftovers frequently leads to overweight dogs. Adipose (fat) tissue is not inert: the Merck Veterinary Manual describes it as the body's largest endocrine organ, secreting a variety of proinflammatory, pain-producing mediators and cytokines. An overweight dog with hip dysplasia will develop OA earlier and more severely than a lean dog with the same underlying anatomy.
Early-onset disease begins silently. Because clinical signs emerge years after the joint damage begins, dogs that are showing their first signs of stiffness at age seven or eight have often been living with the biological process of OA since early adulthood.
Recognising the Signs: What Arthritis Actually Looks Like
This is where most dog owners get surprised. Arthritis in dogs does not look like a dog dramatically limping and crying. It looks like this:
Slowness to rise. Your dog takes noticeably longer to get up after sleeping or resting. She initiates with her forelimbs, then hoists up her hindlimbs a pattern the Merck Veterinary Manual Professional Version specifically identifies as a classic OA sign. You might assume she's just drowsy. She's bracing against joint stiffness.
Reluctance to climb stairs or jump. A dog that used to leap into the car now pauses at the bumper. A dog that bounded up the stairs now hesitates. This is not stubbornness or laziness it is the dog's rational response to pain.
Shorter walks or lagging behind. Your dog used to pull on the leash; now she walks at a slower pace and wants to turn back sooner. Post-exercise stiffness orse the following morning after a long walk is characteristic.
Lameness that may be subtle and shifting. The Merck Veterinary Manual makes an important observation: lameness may be less apparent than expected not only with early disease, but even with advanced bilateral disease. When both hips hurt equally, there is no obvious limp the dog just moves stiffly overall.
Muscle wasting over the hindquarters or shoulders. When a dog consistently avoids loading a joint, the muscles around it atrophy. A dog with hip OA will have noticeably thinner thigh and buttock muscles. A dog with elbow OA may show muscle loss over the shoulder. This is a physical examination finding, but owners can often notice it at home.
Personality changes. An arthritic dog may become irritable when touched around affected joints, avoid social interaction, snap unexpectedly when approached from behind, or seem generally subdued. Chronic pain changes personality in dogs as in people. Our blog on How to Prevent Lethargy in Your Dog covers the signs of pain-related behaviour change in detail.
Licking at a joint. Some dogs lick constantly at the skin overlying a painful joint. The skin may look normal, but the licking is a pain behaviour.
The morning-after pattern. Arthritis pain in dogs is often worst after periods of rest following activity. A dog that seemed fine during a walk may be obviously stiff and slow the next morning. This correlates exactly with the human experience of OA.
How Is Arthritis Diagnosed?
Your vet will take a full history, conduct a physical examination, and use imaging to confirm the diagnosis and its severity.
Physical examination includes gently moving each joint through its full range of motion to detect crepitation (a grating sensation or sound from bone-on-bone contact), resistance, asymmetrical muscle mass, joint swelling, and pain response. The vet also observes the dog moving and assesses gait.
X-rays (radiography) are the primary diagnostic imaging tool. The Merck Veterinary Manual describes their usefulness for determining the degree of arthritis and planning treatment. Radiographic changes in OA include joint effusion, periarticular soft tissue swelling, osteophytosis (bone spurs), subchondral bone sclerosis, and a narrowed joint space.
A critical clinical point: the Merck Veterinary Manual Professional Version states explicitly that treatment should be based on clinical signs rather than radiographic findings alone. Some dogs with dramatic X-ray changes are in modest pain; others with relatively modest changes can be in significant pain, especially those with a neuropathic component. The dog's behaviour, quality of life, and owner's observations are central to treatment decisions.
The COAST staging system Canine Osteoarthritis Staging Tool gives clinicians a structured 0–4 scale based on risk factors, owner observations, physical exam findings, and X-ray results. It was developed to standardise OA diagnosis and monitoring. Your vet may not use this terminology explicitly, but the framework underlies modern OA management in dogs.
Validated pain assessment tools are available for owners to complete at home, including the Canine Brief Pain Inventory and the Liverpool Osteoarthritis in Dogs (LOAD) questionnaire. These allow owners to track pain levels and activity limitations over time providing objective data for monitoring treatment response.
Medical Management: The Multimodal Approach
The Merck Veterinary Manual describes treatments as either medical or surgical. Medical treatment includes weight loss (if needed), exercise on soft surfaces, warm compresses to affected joints, NSAIDs, corticosteroids, and joint fluid modifiers.
The professional version expands this into a full multimodal management framework because no single treatment addresses all the mechanisms of OA pain. The most effective management combines several approaches.
1. Weight Optimisation — The Single Most Impactful Intervention
The Merck Veterinary Manual Professional Version describes weight optimisation as the primary preventive method to slow development of OA in dogs and states it is imperative for overweight patients. The evidence is unambiguous: even modest weight loss produces meaningful improvement in mobility and pain in overweight dogs with OA.
Adipose tissue actively drives OA through proinflammatory cytokines. It is not a passive burden on the joints it is an active contributor to the pain cycle. A dog that loses even 6–8% of body weight from a previously overweight baseline can show clinically meaningful improvement in lameness scores.
How to assess: ideally, you should feel your dog's ribs without pressing hard, but not see them. The waist should be visible from above. The abdomen should tuck up from the side. If none of this applies, your dog is likely overweight. Discuss a caloric restriction plan with your vet.
2. Controlled, Regular Exercise
This surprises many owners. Exercise is not harmful to arthritic dogs the right type of exercise is protective and therapeutic.
The Merck Veterinary Manual Professional Version explains that exercise works through multiple mechanisms: it blocks pain signals at the spinal level through gate control theory, activates the endogenous cannabinoid system (the body's natural pain dampeners), and maintains the strength and stability of the joint's supporting soft tissue structures.
Recommended: short to moderate leash walks on soft surfaces (grass, packed earth, sand), gentle swimming (the gold standard muscle maintenance with zero joint impact), controlled on-leash play.
Avoid: high-impact activity (jumping, fetch on concrete), forced exercise that exhausts the dog, long uncontrolled runs that cause significant post-exercise pain. Exercise should be consistent and moderate not sporadic and intense.
3. Warm Compresses
The Merck Veterinary Manual specifically mentions warm compresses to affected joints as part of medical treatment. A warm (not hot) compress applied to swollen joints for 10–15 minutes improves local circulation, relaxes surrounding muscles, and reduces stiffness. This is something owners can do at home between vet visits and is particularly helpful before morning walks in cooler weather.
4. NSAID Therapy — The Most Effective Pharmaceutical Option
NSAIDs (non-steroidal anti-inflammatory drugs) are, as the Merck Veterinary Manual Professional Version states, "the most predictably effective treatment for OA." They address the inflammatory process that emanates from cartilage damage.
Veterinary NSAIDs for dogs include meloxicam, carprofen, deracoxib, grapiprant, and others. These are different from human NSAIDs and are prescribed by weight and health status.
The Merck Veterinary Manual is honest about the tradeoffs: long-term use of NSAIDs can cause gastrointestinal problems including loss of appetite, vomiting, and inflammation of the stomach and intestines. This is why dogs on long-term NSAIDs require periodic kidney and liver function monitoring. Your vet will recommend the appropriate monitoring schedule.
Never give human NSAIDs to your dog. Ibuprofen, aspirin, and naproxen are toxic to dogs. See our blog on Is It Safe to Give Human Medicines to Dogs and Cats? for the full explanation.
Corticosteroids also suppress inflammation, per the Merck Veterinary Manual, but are usually prescribed only for short periods to avoid adverse effects of continued use.
5. Anti-Nerve Growth Factor Monoclonal Antibodies
The Merck Veterinary Manual Professional Version describes a newer drug class bedinvetmab, an injectable monoclonal antibody that targets nerve growth factor (NGF) to reduce neurogenic pain and peripheral sensitisation. It addresses the neuropathic component of OA that NSAIDs do not fully cover. Administered monthly by subcutaneous injection.
This drug class is not in wide use in India yet but is available at specialist veterinary centres in major cities.
6. Additional Pain-Modifying Drugs
For dogs with moderate to severe OA not fully controlled by NSAIDs alone, the Merck Veterinary Manual Professional Version lists adjunctive options your vet may consider:
- Amantadine — an NMDA-receptor antagonist that addresses central sensitisation
- Gabapentin or Pregabalin — calcium channel modulators that reduce neuropathic pain signalling
- Polysulfated glycosaminoglycan (PSGAG) injections or Pentosan polysulfate (PPS) chondroprotective agents that may be more beneficial in earlier stages of OA
7. Acupuncture and Physical Therapy
The Merck Veterinary Manual Professional Version lists acupuncture, therapeutic laser, and pulsed electromagnetic field therapy as non-pharmacological interventions for OA in dogs. These are increasingly available at specialist practices in India's cities and can complement pharmaceutical management particularly for dogs that cannot tolerate full NSAID doses.
The Role of Omega-3 Fatty Acids and Nutraceuticals
The Merck Veterinary Manual Professional Version makes a specific evidence-based statement: EPA supplementation (50–100 mg/kg daily) and EPA-rich diets have been demonstrated to elicit improved gait and mobility and to have an NSAID-sparing effect in dogs with OA. This is a meaningful clinical finding omega-3 EPA supplementation reduces the dose of NSAIDs needed to achieve the same level of pain control.
The same review notes that glucosamine and chondroitin sulfate are widely used, but a systematic review found that the evidence for these compounds alone without other active ingredients did not conclusively support their use for pain management. However, commercial products containing additional ingredients (avocado and soybean unsaponifiables, type II collagen, eggshell membrane, Boswellia, Devil's Claw) may have additional efficacy.
This means the selection of a joint supplement matters. An EPA-containing formulation with documented anti-inflammatory botanicals is better supported than plain glucosamine alone.
FLEXADIN FORTE TABLET by Vetoquinol directly addresses this: it provides Glucosamine HCl (500mg) + Chondroitin Sulfate (400mg) + Omega-3 (EPA 21mg, DHA 14mg) + Devil's Claw (150mg) + Boswellia Serrata (50mg) + Curcuma Longa (50mg) + Vitamin E. This multi-ingredient profile matches the Merck framework for effective OA supplementation. Chewable, once-daily, suitable for all sizes. Up to 15% OFF on Animeal.
MEGAFLEX POWDER by Bayer provides Glucosamine Sulfate (1000mg/scoop) + MSM (500mg/scoop) + Sea Cucumber (glycosaminoglycans, 300mg/scoop). The powder format mixes easily into food practical for large breed dogs with arthritis who may resist tablet administration. Suitable for all life stages. Up to 15% OFF on Animeal.
For dogs who benefit from dietary management of both weight and joint health, VET PRO MOBILITY DRY FOOD is a complete veterinary diet incorporating Norwegian salmon oil (omega-3), green-lipped mussel extract (a natural source of glucosamine with documented anti-inflammatory properties), chondroitin, and collagen protein. Particularly useful for dogs where both weight management and joint support are needed simultaneously. Up to 15% OFF on Animeal.
Important clarification: these supplements support cartilage and reduce inflammation. They work best when combined with weight management, exercise modification, and NSAIDs where needed. They are not a substitute for veterinary diagnosis and prescription pain management.
Surgical Options
Surgery is not the first-line response to OA but it has a defined role when medical management is insufficient, or when the underlying structural cause warrants it.
The Merck Veterinary Manual lists surgical options as arthroscopy, joint stabilisation or fusion, and joint replacement.
Arthroscopy — a minimally invasive procedure using a small camera inserted into the joint. Used to diagnose and treat specific problems inside the joint removing loose cartilage fragments, treating OCD lesions, or assessing cruciate ligament damage before they progress to severe OA.
Joint stabilisation — surgical procedures that address the underlying instability driving OA. For cruciate ligament disease (the most common cause of stifle OA in dogs), TPLO (Tibial Plateau Leveling Osteotomy) or TTA (Tibial Tuberosity Advancement) stabilise the knee and slow OA progression. Early intervention before arthritis becomes advanced improves outcomes significantly.
Joint fusion (arthrodesis) — fusing the bones of a joint together, eliminating movement at that joint and therefore eliminating pain from it. Most commonly performed on the carpus (wrist) and tarsus (ankle) when those joints have end-stage OA.
Joint replacement — total hip replacement is available in India at specialist referral centres. It is the most complete solution for severe hip OA, restoring near-normal function and eliminating the joint as a pain source. The Merck Veterinary Manual notes the outlook for recovery depends on the location and severity of the joint disease.
The key principle: surgical options are most beneficial when used early before severe degenerative changes have developed and when the patient has a specific structural problem that surgery can address.
Home Adaptations: Making Life Easier for an Arthritic Dog
The medical management plan matters. So does the environment your dog lives in. Several practical home changes can meaningfully reduce daily pain and improve quality of life.
Flooring. Smooth tiled and marble floors the norm in Indian homes are difficult and painful for arthritic dogs. Every step requires extra muscular effort to maintain balance. Place yoga mats, rubber-backed carpet runners, or anti-slip bath mats on the dog's main movement paths. Focus on the route from the sleeping spot to food and water, and to the exit. Non-slip toe grips (applied to the claws) are another option.
Orthopaedic bedding. A thick memory foam bed that doesn't bottom out when the dog lies down significantly reduces pressure on painful joints during the 12–16 hours a day your dog spends resting. Place it in a draught-free corner away from direct cold air (relevant during monsoon and winter in northern India).
Raised food and water bowls. For dogs with cervical (neck) or shoulder OA, bending the neck down to floor-level bowls causes pain and may discourage eating. Raised bowls eliminate this problem.
Ramps instead of stairs. A gentle ramp for entering and exiting a car, climbing onto the sofa (if permitted), or navigating a step into the house significantly reduces the loading impact on arthritic joints compared to jumping.
Temperature. Arthritic pain typically worsens in cold, damp weather a relevant concern during India's winters and rainy season. Provide warm bedding, consider a light dog coat for early morning walks, and ensure the resting area is dry and insulated from floor cold.
Predictable routine. Arthritic dogs benefit from a consistent daily pattern same walk times, same feeding times. They adapt their activity level around predictable rest and movement windows, which reduces pain flare-ups.
FAQ
My 4-year-old Labrador seems perfectly fine — can he still have arthritis?
Possibly. Up to 40% of dogs aged 8 months to 4 years already have radiographic changes of OA, per the Merck Veterinary Manual Professional Version but clinical signs typically don't appear until 5–13 years. Your 4-year-old Labrador is in the highest-risk breed for hip and elbow disease. If you haven't done a baseline hip and elbow X-ray, now is a good time. It establishes what's normal for that dog and allows comparison if symptoms develop later.
Is arthritis in dogs the same as arthritis in people?
In many ways, yes. The underlying biology cartilage breakdown, osteophyte formation, synovitis, pain is the same. The Merck Veterinary Manual notes that the canine disease is, in some ways, more severe: it often begins earlier in life and depends more heavily on inherited skeletal conformational problems. One key difference is that human arthritis often emerges in weight-bearing joints in middle age from accumulated wear; in dogs, it frequently originates from developmental abnormalities. The management principles weight, exercise, anti-inflammatories, nutraceuticals map closely between species.
My vet prescribed NSAIDs but I'm worried about long-term use. Is there an alternative?
The concern is valid long-term NSAID use requires kidney and liver monitoring, and GI effects are a known risk. However, the Merck Veterinary Manual is clear that NSAIDs are the most predictably effective treatment for OA, and that for dogs with moderate to severe clinical signs, sustained use may be appropriate with monitoring. The goal is not to eliminate NSAIDs but to use them responsibly at the lowest effective dose, with periodic blood monitoring, and combined with omega-3 supplementation (which has an NSAID-sparing effect). Discuss a monitoring protocol with your vet rather than stopping NSAIDs unilaterally.
How fast does arthritis progress?
OA is a progressive condition it gets worse over time, not better. However, the rate of progression varies enormously. A lean dog with mild hip dysplasia who exercises regularly and is well-managed can maintain good mobility well into old age. An overweight dog with the same underlying condition who receives no management will deteriorate much faster. The Merck Veterinary Manual Key Points section explicitly states: "Preventive and therapeutic measures should begin far earlier than has historically been the case." Early intervention is meaningful.
Can you tell if a dog is in pain just by looking at them?
Often not. Dogs evolved as prey and predator animals for whom showing pain or weakness was dangerous. Most arthritic dogs do not vocalise pain. They adapt their movement patterns, reduce activity, and change behaviour none of which screams "I'm in pain" the way a crying dog would. The most reliable signals are behavioural: slower rising, reluctance to do things they previously did easily, changed personality around handling. The Early Illness Signs: When to Call the Vet blog covers the full range of behavioural changes that signal hidden pain.
References
- Joseph Harari, MS, DVM, DACVS — Osteoarthritis (Degenerative Joint Disease), Merck Veterinary Manual (Modified October 2024). https://www.merckvetmanual.com/dog-owners/bone-joint-and-muscle-disorders-of-dogs/osteoarthritis-degenerative-joint-disease
- Mark E. Epstein, DVM, DABVP, CVPP — Osteoarthritis in Dogs and Cats (Professional Version), Merck Veterinary Manual (Modified August 2025). https://www.merckvetmanual.com/musculoskeletal-system/osteoarthritis-in-dogs-and-cats/osteoarthritis-in-dogs-and-cats
- Cachon T. et al. — COAST Development Group's International Consensus Guidelines for the Treatment of Canine Osteoarthritis, Frontiers in Veterinary Science. 2023. (Cited in Merck Veterinary Manual Professional Version Reference 4.)
- Merck Veterinary Manual — Joint Disorders in Animals (Professional Version) — 80–90% prevalence estimate. https://www.merckvetmanual.com/musculoskeletal-system/musculoskeletal-system-introduction/joint-disorders-in-animals
